ArticleAdvances in therapy2015

Effect of rivaroxaban versus warfarin on health care costs among nonvalvular atrial fibrillation patients: observations from rivaroxaban users and matched warfarin users.

François Laliberté et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.